Acuitas Group Holdings Amends BioVie Stake Filing

TL;DR

Acuitas Group Holdings filed an update on their BioVie Inc. stake. Check for new details.

AI Summary

Acuitas Group Holdings, LLC, led by Terren S. Peizer, filed an amendment (No. 10) to its Schedule 13D on June 25, 2024, regarding its holdings in BioVie Inc. The filing indicates a change in the date of the event requiring the filing to June 21, 2024. Acuitas Group Holdings, LLC is based in Santa Monica, CA, and BioVie Inc. is incorporated in Nevada.

Why It Matters

This amendment signals a potential shift or update in the significant ownership stake held by Acuitas Group Holdings in BioVie Inc., which could influence market perception and trading activity.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often indicate changes in significant shareholder positions, which can lead to increased volatility and uncertainty.

Key Players & Entities

• Acuitas Group Holdings, LLC (company) — Filing entity
• Terren S. Peizer (person) — Authorized person for notices and communications
• BioVie Inc. (company) — Subject company

FAQ

Key Financial Figures

• $0.0001 — ssuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• tm2418170d1_sc13da.htm (SC 13D/A) — 49KB
• 0001104659-24-074862.txt ( ) — 50KB

of the Statement is

Item 2 of the Statement is hereby amended and supplemented by adding the following: “On June 21, 2024, Mr. Peizer was found guilty by a jury in the Central District of California of one count of securities fraud and two counts of insider trading. The allegations related to the sale of shares of Ontrak, Inc. through the use of two Rule 10b5-1 trading plans. Mr. Peizer’s conviction is not yet final, and he plans to appeal the verdict. Other than as set forth above, during the last five years, no Reporting Person has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) and no Reporting Person has been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction as a result of which such Reporting Person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.” ITEM 5. INTEREST IN SECURITIES OF THE ISSUER Items 5(a) and (b) of the Statement are hereby amended and restated as follows: “(a) and (b) Acuitas All percentages of shares of Common Stock contained herein with respect to Acuitas are based on 68,438,249 shares of Common Stock deemed outstanding pursuant to Rule 13d-3(d)(1), calculated as the sum of (i) 61,165,521 shares of Common Stock outstanding as of June 13, 2024, as reported by the Issuer in the Definitive Proxy Statement with respect to its Special Meeting of Stockholders filed with the SEC on June 17, 2024 (the “ DEF14A ”), and (ii) 7,272,728 shares of Common Stock that may be issued to Acuitas upon exercise of a warrant previously issued to Acuitas (the “ Warrant ”). As of June 25, 2024, Acuitas may be deemed to have beneficial ownership of 30,435,738 shares of Common Stock, consisting of (i) an aggregate of 23,163,010 shares of Common Stock held directly by Acui

(c) of the Statement

Item 5(c) of the Statement is hereby supplemented with the following: “The Reporting Persons had no transactions in the securities of the Company during the past sixty days.” SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: June 25, 2024 ACUITAS GROUP HOLDINGS, LLC By: /s/ Terren S. Peizer Terren S. Peizer, Chairman /s/ Terren S. Peizer Terren S. Peizer

View Full Filing

View this SC 13D/A filing on SEC EDGAR